Sign In
Buy MEDIF
$0.0539
-0.0024 (-4.33%)
At Close: Jun 03, 2026
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
08:00am, Thursday, 28'th May 2026
Annual and Special Meeting to be held virtually on Wednesday, June 17, 2026 at 11:00 a.m. (Eastern Time).
MediPharm Labs Corp. (LABS:CA) Q1 2026 Earnings Call Transcript
11:30am, Wednesday, 13'th May 2026
MediPharm Labs Corp. (LABS:CA) Q1 2026 Earnings Call Transcript
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
07:30am, Wednesday, 13'th May 2026
Q1 2026 Positive Adjusted EBITDA(1) Net Revenue of $9M with strong gross margins of 37% OPEX decreased 28% in Q1 2026 versus Q4 2025 Company is virtually debt free, with a Q1 ending cash balance of $9
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
08:05pm, Thursday, 07'th May 2026
TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS ) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precis
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
08:30am, Monday, 27'th Apr 2026
On April 22, 2026, the U.S. Department of Justice and Drug Enforcement Administration's final order rescheduling FDA-approved cannabis drug products and state-licensed medical cannabis from Schedule I
MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript
11:52am, Monday, 30'th Mar 2026
MediPharm Labs Corp. (LABS:CA) Q4 2025 Earnings Call Transcript
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
07:45am, Monday, 30'th Mar 2026
FY 2025 revenue of $45.1 million, an increase of 8% over 2024 International Medical Cannabis revenue increased 43% year-over-year and represented more than 50% of total revenue Increased cash balance
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
07:05pm, Wednesday, 25'th Mar 2026
MediPharm Labs will release its financial results for the three & twelve months ended December 31st, 2025, before markets open on Monday, March 30th, 2026.
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
08:00am, Monday, 19'th Jan 2026
TORONTO, Jan. 19, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm" or the "Company"), a pharmaceutical company specialized in precision-based cannabinoi
MediPharm Labs to Enter New Market with Costa Rica Supply Agreement
08:00am, Tuesday, 13'th Jan 2026
TORONTO, Jan. 13, 2026 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm”, “MediPharm Labs” or the “Company”), a pharmaceutical company specialized
TORONTO, Dec. 19, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns
08:30pm, Wednesday, 10'th Dec 2025
TORONTO, Dec. 10, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ca
MediPharm Labs Completes First Shipment to France
08:40am, Thursday, 04'th Dec 2025
TORONTO, Dec. 04, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in precisio
TORONTO, Nov. 14, 2025 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) (“MediPharm” or the “Company”), a pharmaceutical company specialized in precision-based ca
MediPharm Labs Corp. (LABS:CA) Q3 2025 Earnings Call Transcript
12:01pm, Thursday, 13'th Nov 2025
MediPharm Labs Corp. ( LABS:CA ) Q3 2025 Earnings Call November 13, 2025 10:00 AM EST Company Participants David Pidduck - CEO & Director Greg Hunter - Chief Financial Officer Presentation Operator Th
